# Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients

> **NCT02675647** · PHASE4 · COMPLETED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 60 (estimated)

## Conditions studied

- Cardiac Surgery
- Cardiopulmonary Bypass
- Obese Patients (BMI ≥ 30 kg/m²)

## Interventions

- **DRUG:** Heparin, IV route, based on patients body weights (UI/kg)
- **PROCEDURE:** Cardiopulmonary bypass
- **DRUG:** Protamin administration

## Key facts

- **NCT ID:** NCT02675647
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-12
- **Final completion:** 2017-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02675647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02675647, "Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02675647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*